TLRs antiviral effect on hepatitis B virus in HepG2 cells

被引:34
|
作者
Xia, C. [1 ]
Lu, M. [1 ]
Zhang, Z. [2 ]
Meng, Z. [2 ]
Zhang, Z. [2 ]
Shi, C. [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Clin Immunol,Dept Infect Dis, Wuhan 430030, Peoples R China
关键词
antiviral effect; HBV; HepG2; Toll-like receptors;
D O I
10.1111/j.1365-2672.2008.03896.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: A hepatoma cell line, HepG2, was used as a model system to detect Toll-like receptor (TLR) expression in hepatocytes and examine the antiviral effect on hepatitis B virus (HBV). Methods and Results: Toll-like receptor expression was detected in HepG2 cells by RT-PCR. The TLRs, which were strongly expressed in HepG2 cells, were stimulated with specific ligands. Interferon (IFN) response was evaluated poststimulation with Western blotting for signal transduction and activators of transcription-1. Furthermore, HepG2 cells were transiently transfected with wild-type HBV 1.3-fold over-length plasmid and treated with specific ligands at indicated times. Replication of HBV DNA, transcription of HBV RNA intermediate and expression of HBV antigens were respectively detected by Southern blotting, real time PCR, ELISA and Western blotting. Activation of different TLRs induced antiviral effects on HBV to varying degrees. Conclusions: The TLRs, which were strongly expressed in HepG2 cells, could be stimulated with specific ligands. Activation of TLRs induced apparent production of antiviral cytokines such as IFN-alpha/beta and inhibited HBV lifecycle in the hepatocyte cell model. Significance and Impact of the Study: Expression of TLRs in hepatocytes may be related to local immunity of liver and participate in the outcome of viral hepatitis.
引用
收藏
页码:1720 / 1727
页数:8
相关论文
共 50 条
  • [21] Limited proteolysis induces woodchuck hepatitis virus infectivity for human HepG2 cells
    Lu, XY
    Hazboun, T
    Block, T
    VIRUS RESEARCH, 2001, 73 (01) : 27 - 40
  • [22] HepG2 Cells Mount an Effective Antiviral Interferon-Lambda Based Innate Immune Response to Hepatitis C Virus Infection
    Israelow, Benjamin
    Narbus, Christopher M.
    Sourisseau, Marion
    Evans, Matthew J.
    HEPATOLOGY, 2014, 60 (04) : 1170 - 1179
  • [23] TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
    X Zhu
    C Xie
    Y-m Li
    Z-l Huang
    Q-y Zhao
    Z-x Hu
    P-p Wang
    Y-r Gu
    Z-l Gao
    L Peng
    Cell Death & Disease, 2016, 7 : e2239 - e2239
  • [24] Stably transfected HepG2 cells support consistent hepatitis C virus replication
    Sun, B
    Pan, JB
    Clayton, M
    Gerber, M
    Feitelson, M
    FASEB JOURNAL, 2003, 17 (04): : A252 - A252
  • [25] Hepatitis C virus core protein expression in HepG2 cells using Semliki Forest Virus
    Mira-Gonzalez, Catalina
    Orlando Yepes, Jesus
    Felipe Henao, Luis
    Montoya-Guzman, Melissa
    Navas, Maria-Cristina
    ACTA BIOLOGICA COLOMBIANA, 2021, 26 (01): : 72 - 80
  • [26] A New Cell Culture System for Infection with Hepatitis B Virus that Fuses HepG2 Cells with Primary Human Hepatocytes
    Jiang, Y.
    Wang, A. H.
    Shao, L. H.
    Wang, G.
    Yao, Y. Y.
    Sai, L. T.
    Chen, F. Z.
    Zheng, F.
    Li, Y.
    Ma, L. X.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (03) : 650 - 661
  • [27] The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage
    Lee, ATC
    Ren, JW
    Wong, ET
    Ban, KHK
    Lee, LA
    Lee, CGL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (39) : 33525 - 33535
  • [28] Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
    Iwamoto, Masashi
    Watashi, Koichi
    Tsukuda, Senko
    Aly, Hussein Hassan
    Fukasawa, Masayoshi
    Fujimoto, Akira
    Suzuki, Ryosuke
    Aizaki, Hideki
    Ito, Takayoshi
    Koiwai, Osamu
    Kusuhara, Hiroyuki
    Wakita, Takaji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (03) : 808 - 813
  • [29] TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway
    Zhu, X.
    Xie, C.
    Li, Y-m
    Huang, Z-l
    Zhao, Q-y
    Hu, Z-x
    Wang, P-p
    Gu, Y-r
    Gao, Z-l
    Peng, L.
    CELL DEATH & DISEASE, 2016, 7 : e2239 - e2239
  • [30] LOCALIZATION OF (PRO)THYMOSIN ALPHA-1-LIKE ANTIGEN IN HEPG2 CELLS AND HEPATITIS-B VIRUS TRANSFECTED-HEPG2 CELLS BY IMMUNOCYTOCHEMICAL LABELING
    SASAKI, DM
    MOSHIER, JA
    MUTCHNICK, MG
    GASTROENTEROLOGY, 1994, 106 (04) : A976 - A976